Naomi L. Kruhlak

In silico toxicology protocols

Glenn J. Myatt, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2018 · 241 citations · Full text

Pharmacy, Toxicology, Developmental Toxicology +11

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints

Edwin J. Matthews, Naomi L. Kruhlak, Michael C. Cimino et al. · Regulatory Toxicology and Pharmacology · 2005 · 135 citations

Pharmacy, Genetics, Toxicology +17

Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses

Alexander Amberg, Lisa Beilke, Joel P. Bercu et al. · Regulatory Toxicology and Pharmacology · 2016 · 113 citations · Full text

Pharmacy, Toxicology, Analytical Toxicology +16

An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods

Edwin J. Matthews, Naomi L. Kruhlak, Michael C. Cimino et al. · Regulatory Toxicology and Pharmacology · 2005 · 97 citations

Pharmacy, Genetics, Toxicology +17

(Q)SAR Modeling and Safety Assessment in Regulatory Review

Naomi L. Kruhlak, R. Benz, Hongfei Zhou et al. · Clinical Pharmacology & Therapeutics · 2012 · 93 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17